Also known as type 1.5 diabetes, here’s what to know about the onset, symptoms, diagnosis, and treatment options for latent ...
Clinical Trials Arena on MSN4d
Vertex halts development of diabetes cell therapy after trial failureVertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.
Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...
Low levels of soluble neuropilin-1 are associated with depression in patients with newly diagnosed type 2 diabetes, ...
Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
WFS1 and CISD2 regulate IP3R activity through their interaction. In Wolfram syndrome, their dysfunction reduces cytosolic ...
Biomea Fusion (BMEA) announced the presentation of preclinical and clinical data from studies assessing icovamenib at the Advanced Technologies ...
Vertex Pharmaceuticals will not advance clinical trials of a treatment for Type 1 diabetes after efficacy data failed to support further clinical advancement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback